We are live on
!
Find out more
RFC
Russell Frank Company Portfolio holdings
AUM
$56.9B
1-Year Est. Return
2.13%
This Fund
S&P 500
This Quarter
Est. Return
+0.49%
1 Year Est. Return
+2.13%
3 Year Est. Return
+42.95%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$62.3B
AUM Growth
+$7.85B
(+14%)
Cap. Flow
+$8.31B
Cap. Flow
% of AUM
13.34%
Top 10 Holdings %
Top 10 Hldgs %
9.97%
Holding
3,191
New
223
Increased
1,928
Reduced
784
Closed
153
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$168M |
| 2 |
Wells Fargo
WFC
|
+$139M |
| 3 |
Alphabet (Google) Class C
GOOG
|
+$129M |
| 4 |
Johnson & Johnson
JNJ
|
+$124M |
| 5 |
ExxonMobil
XOM
|
+$123M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Perrigo
PRGO
|
+$77M |
| 2 |
TSMC
TSM
|
+$47M |
| 3 |
Franklin Resources
BEN
|
+$46.8M |
| 4 |
AET
Aetna Inc
AET
|
+$44.4M |
| 5 |
Archer Daniels Midland
ADM
|
+$43.3M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 19.12% |
| 2 | Healthcare | 12.77% |
| 3 | Technology | 11.87% |
| 4 | Industrials | 11.15% |
| 5 | Consumer Discretionary | 9.48% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1726
Matsons
MATX
$6.18B
| $3.07M | ﹤0.01% |
73,014
+13,745
| +23% | +$576K |
|
1727
Lands' End
LE
$403M
| $3.06M | ﹤0.01% |
123,393
+83,990
| +213% | +$2.41M |
|
|
NGD
1728
DELISTED
New Gold Inc
NGD
| $3.05M | ﹤0.01% |
1,135,483
+668,909
| +143% | +$2.19M |
|
|
AFSI
1729
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $3.05M | ﹤0.01% |
93,030
+7,566
| +9% | +$228K |
|
|
CPE
1730
DELISTED
Callon Petroleum Company
CPE
| $3.04M | ﹤0.01% |
36,516
+6,528
| +22% | +$542K |
|
1731
HubSpot
HUBS
$10.5B
| $3.03M | ﹤0.01% |
61,030
+39,421
| +182% | +$1.81M |
|
|
CSFL
1732
DELISTED
CenterState Bank Corporation Common Stock
CSFL
| $3.02M | ﹤0.01% |
223,890
+61,013
| +37% | +$771K |
|
1733
Ingles Markets
IMKTA
$1.67B
| $3.02M | ﹤0.01% |
63,265
+19,465
| +44% | +$939K |
|
|
AVP
1734
DELISTED
Avon Products, Inc.
AVP
| $3.02M | ﹤0.01% |
480,711
+97,063
| +25% | +$721K |
|
1735
Allient
ALNT
$1.92B
| $3M | ﹤0.01% |
200,490
+78,741
| +65% | +$1.58M |
|
|
FFG
1736
DELISTED
FBL Financial Group
FFG
| $3M | ﹤0.01% |
51,984
+6,552
| +14% | +$388K |
|
1737
Genpact
G
$5.76B
| $3M | ﹤0.01% |
140,548
+72,760
| +107% | +$1.63M |
|
|
CIM
1738
Chimera Investment
CIM
$1B
| $3M | ﹤0.01% |
72,867
-84,874
| -54% | -$3.79M |
|
|
PPP
1739
DELISTED
Primero Mining Corp
PPP
| $2.99M | ﹤0.01% |
767,772
+112,154
| +17% | +$440K |
|
|
DNY
1740
DELISTED
DONNELLEY R R & SONS CO
DNY
| $2.99M | ﹤0.01% |
171,333
+92,749
| +118% | +$1.62M |
|
1741
REX American Resources
REX
$1.41B
| $2.98M | ﹤0.01% |
281,142
-1,044
| -0.4% | -$11K |
|
|
MTOR
1742
DELISTED
MERITOR, Inc.
MTOR
| $2.98M | ﹤0.01% |
227,021
+11,184
| +5% | +$150K |
|
|
CPHD
1743
DELISTED
Cepheid Inc
CPHD
| $2.98M | ﹤0.01% |
48,689
+16,552
| +52% | +$944K |
|
|
TXNM
1744
TXNM Energy Inc
TXNM
$5.94B
| $2.97M | ﹤0.01% |
120,595
+25,720
| +27% | +$688K |
|
|
SCMP
1745
DELISTED
Sucampo Pharmaceuticals, Inc.
SCMP
| $2.97M | ﹤0.01% |
180,517
+121,638
| +207% | +$2.11M |
|
1746
TTM Technologies
TTMI
$14.5B
| $2.96M | ﹤0.01% |
+296,700
| New | +$2.89M |
|
|
HUB.B
1747
DELISTED
HUBBELL INC CL-B
HUB.B
| $2.96M | ﹤0.01% |
27,334
+10,765
| +65% | +$1.18M |
|
|
AMSG
1748
DELISTED
Amsurg Corp
AMSG
| $2.96M | ﹤0.01% |
42,324
+8,534
| +25% | +$570K |
|
|
WEB
1749
DELISTED
Web.com Group, Inc.
WEB
| $2.96M | ﹤0.01% |
122,062
+109,648
| +883% | +$2.38M |
|
|
INFI
1750
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $2.96M | ﹤0.01% |
269,881
+86,647
| +47% | +$1.11M |
|
Similar funds
VRS
ACM
BKBG
CAM
FMA
KG
NPIT
AIA
Russell Frank Company's Q2 2015 Portfolio in Review
As of Q2 2015, Russell Frank Company held 3,191 positions worth $62.3B, up 14% from $54.5B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Russell Frank Company deployed $8.31B of net new capital in Q2 2015, opening 223 new positions and adding to 1,928 existing holdings. Its largest new stake was iShares MBS ETF: 686,878 shares worth $74.7M.
By sector, the portfolio is most concentrated in Financials at 19% of assets, up from 18% a quarter earlier, followed by Healthcare and Technology.
On the sell side, the largest reduction was Perrigo, an estimated $77M trimmed.
- Russell Frank Company's largest Q2 2015 buy was iShares MBS ETF: 686,878 shares worth $74.7M.
- Russell Frank Company added most to Merck in Q2 2015, an estimated $168M increase.
- Russell Frank Company's biggest Q2 2015 reduction was Perrigo, cutting an estimated $77M.
- Russell Frank Company fully exited USB AG (NEW) in Q2 2015, selling an estimated $19.9M.
- Russell Frank Company's ten largest holdings make up 10% of its $62.3B portfolio in Q2 2015.
- Russell Frank Company opened 223 new positions and closed 153 in Q2 2015.
- Russell Frank Company's portfolio value rose 14% quarter-over-quarter to $62.3B.
Based on Russell Frank Company's 13F filing for Q2 2015, filed 13 Aug 2015.